Literature DB >> 19649556

Management and outcomes of anorectal infection in the cancer patient.

Brian D Badgwell1, George J Chang, Miguel A Rodriguez-Bigas, Kerrington Smith, Philip J Lupo, Ralph F Frankowski, George Delclos, Xianglin L Du, Janice Cormier.   

Abstract

BACKGROUND: The objective of this retrospective cohort study is to examine the presentation and outcomes for a contemporary series of cancer patients with anorectal infection. In addition, we seek to identify factors which are associated with surgical intervention.
METHODS: The study cohort was identified from International Classification of Disease (ICD)-9 codes for diagnosis of infection of the anal and rectal region and patients who underwent a surgical oncology consultation at The University of Texas M.D. Anderson Cancer Center between 1/2000 and 12/2006. Clinical presentation, treatment rendered, and outcomes were retrospectively recorded.
RESULTS: Of the 100 patients evaluated by the surgical oncology service for anorectal infection, 42 were treated nonoperatively and 58 underwent surgical intervention. Factors associated with surgical intervention based on logistic multivariable analysis included diagnosis of an abscess [odds ratio (OR) 10.5, 95% confidence interval (CI) 2.9-38.5] and documentation of erythema on physical examination (OR 3.1, 95% CI 1.1-8.4). Thrombocytopenia (platelets <50,000) was associated with nonoperative management (OR 0.3, 95% CI 0.1-0.7). Incision and drainage was the most common surgical procedure (79%) while a wide debridement for a necrotizing soft tissue infection was required in two patients. Infection-specific 90-day mortality was 1% (n = 1), attributable to a necrotizing infection. However, median overall survival for the entire cohort was only 14.4 months (95% CI 7.9-19.5 months).
CONCLUSIONS: Identification of an abscess, erythema on physical exam, and thrombocytopenia were associated with management strategy. Although rare, necrotizing soft tissue infections are associated with significant mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649556     DOI: 10.1245/s10434-009-0626-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

Review 1.  Anorectal emergencies: WSES-AAST guidelines.

Authors:  Antonio Tarasconi; Gennaro Perrone; Justin Davies; Raul Coimbra; Ernest Moore; Francesco Azzaroli; Hariscine Abongwa; Belinda De Simone; Gaetano Gallo; Giorgio Rossi; Fikri Abu-Zidan; Vanni Agnoletti; Gianluigi de'Angelis; Nicola de'Angelis; Luca Ansaloni; Gian Luca Baiocchi; Paolo Carcoforo; Marco Ceresoli; Alain Chichom-Mefire; Salomone Di Saverio; Federica Gaiani; Mario Giuffrida; Andreas Hecker; Kenji Inaba; Michael Kelly; Andrew Kirkpatrick; Yoram Kluger; Ari Leppäniemi; Andrey Litvin; Carlos Ordoñez; Vittoria Pattonieri; Andrew Peitzman; Manos Pikoulis; Boris Sakakushev; Massimo Sartelli; Vishal Shelat; Edward Tan; Mario Testini; George Velmahos; Imtiaz Wani; Dieter Weber; Walter Biffl; Federico Coccolini; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-09-16       Impact factor: 5.469

Review 2.  Management of acute perianal sepsis in neutropenic patients with hematological malignancy.

Authors:  B Baker; M Al-Salman; F Daoud
Journal:  Tech Coloproctol       Date:  2013-11-26       Impact factor: 3.781

Review 3.  Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient.

Authors:  Michael G White; Ryan B Morgan; Michael W Drazer; Oliver S Eng
Journal:  J Gastrointest Surg       Date:  2021-09-10       Impact factor: 3.452

4.  A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases.

Authors:  Camila Perazzoli; Rogério S Parra; Marley R Feitosa; Enrico Sfoggia; Belinda Pinto Simões; José J R Rocha; Omar Féres
Journal:  Gastroenterol Res Pract       Date:  2019-03-24       Impact factor: 2.260

5.  The Role of White Blood Cell Count in Perianal Pathologies: A Retrospective Analysis of Hematologic Malignancies.

Authors:  Bedrettin Orhan; Fahir Özkalemkaş; Vildan Özkocaman; Büşra Gürbüz; Tuba Ersal; İbrahim Ethem Pınar; Cumali Yalçin; Ömer Candar; Sinem Çubukçu; Tuba Güllü Koca; Rıdvan Ali
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.